Diabetes and Infectious Diseases with a Focus on Melioidosis
- PMID: 38833191
- DOI: 10.1007/s00284-024-03748-z
Diabetes and Infectious Diseases with a Focus on Melioidosis
Abstract
Diabetes mellitus (DM) leads to impaired innate and adaptive immune responses. This renders individuals with DM highly susceptible to microbial infections such as COVID-19, tuberculosis and melioidosis. Melioidosis is a tropical disease caused by the bacterial pathogen Burkholderia pseudomallei, where diabetes is consistently reported as the most significant risk factor associated with the disease. Type-2 diabetes is observed in 39% of melioidosis patients where the risk of infection is 13-fold higher than non-diabetic individuals. B. pseudomallei is found in the environment and is an opportunistic pathogen in humans, often exhibiting severe clinical manifestations in immunocompromised patients. The pathophysiology of diabetes significantly affects the host immune responses that play a critical role in fighting the infection, such as leukocyte and neutrophil impairment, macrophage and monocyte inhibition and natural killer cell dysfunction. These defects result in delayed recruitment as well as activation of immune cells to target the invading B. pseudomallei. This provides an advantage for the pathogen to survive and adapt within the immunocompromised diabetic patients. Nevertheless, knowledge gaps on diabetes-infectious disease comorbidity, in particular, melioidosis-diabetes comorbidity, need to be filled to fully understand the dysfunctional host immune responses and adaptation of the pathogen under diabetic conditions to guide therapeutic options.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Impaired early cytokine responses at the site of infection in a murine model of type 2 diabetes and melioidosis comorbidity.Infect Immun. 2013 Feb;81(2):470-7. doi: 10.1128/IAI.00930-12. Epub 2012 Dec 3. Infect Immun. 2013. PMID: 23208607 Free PMC article.
-
Burkholderia pseudomallei sepsis with osteoarticular melioidosis of the hip in a patient with diabetes mellitus.BMJ Case Rep. 2020 Dec 21;13(12):e238200. doi: 10.1136/bcr-2020-238200. BMJ Case Rep. 2020. PMID: 33370949 Free PMC article.
-
BpOmpW Antigen Stimulates the Necessary Protective T-Cell Responses Against Melioidosis.Front Immunol. 2021 Dec 13;12:767359. doi: 10.3389/fimmu.2021.767359. eCollection 2021. Front Immunol. 2021. PMID: 34966388 Free PMC article.
-
Immunity to Burkholderia pseudomallei.Curr Opin Infect Dis. 2009 Apr;22(2):102-8. doi: 10.1097/QCO.0b013e328322e727. Curr Opin Infect Dis. 2009. PMID: 19276877 Review.
-
Burkholderia pseudomallei septic arthritis in Type-2 diabetes mellitus patients: Report of two cases.Indian J Med Microbiol. 2020 Apr-Jun;38(2):222-225. doi: 10.4103/ijmm.IJMM_20_74. Indian J Med Microbiol. 2020. PMID: 32883939 Review.
Cited by
-
Disseminated Nocardiosis: Poorly Controlled Diabetes as an Immunocompromising State.Cureus. 2025 May 21;17(5):e84590. doi: 10.7759/cureus.84590. eCollection 2025 May. Cureus. 2025. PMID: 40551933 Free PMC article.
-
The Potential Impact of SGLT2-I in Diabetic Foot Prevention: Promising Pathophysiologic Implications, State of the Art, and Future Perspectives-A Narrative Review.Medicina (Kaunas). 2024 Nov 1;60(11):1796. doi: 10.3390/medicina60111796. Medicina (Kaunas). 2024. PMID: 39596981 Free PMC article. Review.
References
-
- Tan SY, Mei Wong JL, Sim YJ, Wong SS, Mohamed Elhassan SA, Tan SH, Ling Lim GP, Rong Tay NW, Annan NC, Bhattamisra SK, Candasamy M (2019) Type 1 and 2 diabetes mellitus: a review on current treatment approach and gene therapy as potential intervention. Diabetes Metab Syndr 13(1):364–372. https://doi.org/10.1016/j.dsx.2018.10.008 - DOI - PubMed
-
- Kahaly GJ, Hansen MP (2016) Type 1 diabetes associated autoimmunity. Autoimmun Rev 15(7):644–648. https://doi.org/10.1016/j.autrev.2016.02.017 - DOI - PubMed
-
- Muoio DM, Newgard CB (2008) Mechanisms of disease: Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 9(3):193–205. https://doi.org/10.1038/nrm2327 - DOI - PubMed
-
- Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, Ostolaza H, Martin C (2020) Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci 21(17):6275. https://doi.org/10.3390/2Fijms21176275 - DOI - PubMed - PMC
-
- Global Burden of Disease Collaborative Network (2020) Global Burden of Disease Study 2019 Results. https://vizhub.healthdata.org/gbd-results/ . Accessed 1 Apr 2024
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources